1SXP — SCHOTT Pharma AG & Co KgaA Share News
0.000.00%
- €2.61bn
- €2.67bn
- €986.21m
Brief: Schott Pharma H1 EBITDA Margin At 26.6%
Barclays flags structural shift to injectables, prefers devices to drug containment
Schott Pharma rises after Q1 sales beat
Brief: SCHOTT Pharma Says Q1 Revenue EUR 240.2 Million
Europe Research Roundup: Flughafen Zuerich, IONOS Group, United Internet
Europe Research Roundup: Allgeier, Heineken, Zehnder Group
Europe Research Roundup: Centrica, IHG, Volvo Car
Brief: Schott Pharma FY EBITDA At EUR 280.3 Mln
BNP picks medtech favourites, sees re-rating in H2 2026
Analysts cut Schott Pharma, expect 2026 to be transition year
European shares on track for weekly gains; US inflation in focus (updated)
European shares steady after three-day rally; focus on US inflation
Schott Pharma falls after mid-term guidance cut
Brief: Schott Pharma Reports FY 2025 Revenue Of EUR 986.2 Mln
Brief: Schott Pharma Says Expects FY 2026 EBITDA Margin Of Around 27%
RBC starts Schott Pharma with 'sector perform', citing uncertain earnings momentum
Europe Research Roundup: CaixaBANK, B&M, H&M
Schott Pharma climbs after Berenberg upgrades to 'buy'
Brief: Schott Pharma Christian Mias To Succeed Andreas Reisse As CEO